Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Pharmaron Beijing Pays Up to $137.5 Million to Acquire Absorption, a US CRO

publication date: Nov 9, 2020

Pharmaron Beijing, a CRO/CMO, acquired Absorption Systems of Philadelphia in a deal work up to $137.5 million. Absorption Systems is a non-clinical CRO that provides research and testing for small and large molecules, cell and gene therapies, ocular and medical device products. It has facilities in Philadelphia, San Diego and Boston. Pharmaron, which offers laboratory, CMC and clinical development services, said the acquisition will increase its global services. More details....

Stock Symbols: (SHZ: 300759; HK: 3759)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital